Completed PHASE1 INTERVENTIONAL 2-arm NCT00866489

The Neuroprotective Effects of RPC on the Neurosurgery

Clinical Trial Cencer, Xijing Hospital, Fourth Military Medical University

Sponsor: Xijing Hospital

Conditions s100b

Updated 5 times since 2017 Last updated: Dec 26, 2010 Started: Sep 30, 2008 Primary completion: Jun 30, 2009 Completion: Sep 30, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00866489, this PHASE1 trial focuses on s100b and remains completed. Sponsored by Xijing Hospital, it has been updated 5 times since 2008, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Sep 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Xijing Hospital

Data source: Xijing Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.